Yaohua He

3.3k total citations · 1 hit paper
41 papers, 1.3k citations indexed

About

Yaohua He is a scholar working on Surgery, Industrial and Manufacturing Engineering and Molecular Biology. According to data from OpenAlex, Yaohua He has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 12 papers in Industrial and Manufacturing Engineering and 11 papers in Molecular Biology. Recurrent topics in Yaohua He's work include Fibroblast Growth Factor Research (10 papers), Scheduling and Optimization Algorithms (10 papers) and Advanced Control Systems Optimization (8 papers). Yaohua He is often cited by papers focused on Fibroblast Growth Factor Research (10 papers), Scheduling and Optimization Algorithms (10 papers) and Advanced Control Systems Optimization (8 papers). Yaohua He collaborates with scholars based in United States, Hong Kong and United Kingdom. Yaohua He's co-authors include Chi‐Wai Hui, Eleanor Boyle, J. David Cassidy, Susan J. Bondy, Sheilah Hogg‐Johnson, Frank L. Silver, Pierre Côté, Karim A. Benhadji, Peter C. Austin and Jean‐Éric Tarride and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Yaohua He

41 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Futibatinib, an Irreversible FGFR1–4 Inhibitor, in Patients with Advanced Solid Tumors Harboring FGF / FGFR Aberrations: A Phase I Dose-Expansion Study

2021 171 citations Funda Meric‐Bernstam, Rastislav Bahleda et al. Cancer Discovery profile →

Peers

Countries citing papers authored by Yaohua He

Since Specialization

Citations

This map shows the geographic impact of Yaohua He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaohua He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaohua He more than expected).

Fields of papers citing papers by Yaohua He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaohua He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaohua He. The network helps show where Yaohua He may publish in the future.

Co-authorship network of co-authors of Yaohua He

This figure shows the co-authorship network connecting the top 25 collaborators of Yaohua He. A scholar is included among the top collaborators of Yaohua He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaohua He. Yaohua He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of the Cytochrome P450 3A and P‐glycoprotein Drug‐Drug Interaction Potential of Futibatinib 2023 ·Clinical Pharmacology in Drug Development ·Ikuo Yamamiya, (unknown), Toru Takenaka, Daryl Sonnichsen, (unknown), Yaohua He, Karim A. Benhadji, Ling Gao	6
2	Evaluation of the Mass Balance and Metabolic Profile of Futibatinib in Healthy Participants 2023 ·Clinical Pharmacology in Drug Development ·Ikuo Yamamiya, (unknown), (unknown), Daryl Sonnichsen, (unknown), Yaohua He, Karim A. Benhadji	8
3	Futibatinib, an Irreversible FGFR1–4 Inhibitor, in Patients with Advanced Solid Tumors Harboring FGF / FGFR Aberrations: A Phase I Dose-Expansion Study breakdown → 2021 ·Cancer Discovery ·Funda Meric‐Bernstam, Rastislav Bahleda, Cinta Hierro, Marc Sanson, John Bridgewater, Hendrik‐Tobias Arkenau, Ben Tran, Robin Kate Kelley, Joon Oh Park, Milind Javle, Yaohua He, Karim A. Benhadji, Lipika Goyal	171
4	A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment 2021 ·Cancer Chemotherapy and Pharmacology ·Muhammad Wasif Saif, Carlos Becerra, Marwan Fakih, Weijing Sun, Lazar Popović, Smitha Krishnamurthi, Thomas J. George, Michelle A. Rudek, Dale R. Shepard, (unknown), Vladimír Šrámek, Bojan Zarić, Ikuo Yamamiya, Karim A. Benhadji, K Hamada, Yaohua He, Lee S. Rosen	6
5	Eribulin, Child-Pugh score, and liver-function tests: lessons from pivotal breast cancer studies 301 and 305 2021 ·Breast Cancer Research ·Iain R. Macpherson, Yaohua He, Carlo Palmieri	4
6	A first-in-human phase I study of TAS0728, an oral covalent binding inhibitor of HER2, in patients with advanced solid tumors with HER2 or HER3 aberrations 2021 ·Investigational New Drugs ·Sarina A. Piha‐Paul, Analía Azaro, (unknown), Do‐Youn Oh, Matthew D. Galsky, Sumanta K. Pal, K Hamada, Yaohua He, Ikuo Yamamiya, Karim A. Benhadji, Antoine Hollebecque	6
7	Single injection Quadratus Lumborum block for postoperative analgesia in adult surgical population: A systematic review and meta-analysis 2020 ·Journal of Clinical Anesthesia ·Zhaosheng Jin, Jiaxin Liu, Ru Li, Tong J. Gan, Yaohua He, Jun Lin	46
8	Phase II Study of Eribulin Mesylate Administered Biweekly in Patients With Human Epidermal Growth Factor Receptor-2–negative Metastatic Breast Cancer 2019 ·Clinical Breast Cancer ·John W. Smith, (unknown), (unknown), Karen L. Tedesco, Soamnauth Misir, Wei Zhu, (unknown), Yaohua He, Ran Xie, Martin Olivo, Joyce O’Shaughnessy	4
9	Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer 2019 ·BMC Cancer ·Lee S. Schwartzberg, Kristi McIntyre, Sharon Wilks, Shannon Puhalla, Joyce O’Shaughnessy, (unknown), Yaohua He, Linda T. Vahdat	5
10	Risk of Vertebrobasilar Stroke and Chiropractic Care 2009 ·Journal of Manipulative and Physiological Therapeutics ·J. David Cassidy, Eleanor Boyle, Pierre Côté, Yaohua He, Sheilah Hogg‐Johnson, Frank L. Silver, Susan J. Bondy	105
11	Meta-Heuristics for Large-Scale Process Scheduling 2009 ·Yaohua He, Chi Wai Hui	3
12	Results of a Population-Based Case-Control and Case-Crossover Study 2008 ·J. David Cassidy, Eleanor Boyle, Yaohua He, Sheilah Hogg‐Johnson, Frank L. Silver, Susan J. Bondy	12
13	Risk of Vertebrobasilar Stroke and Chiropractic Care 2008 ·European Spine Journal ·J. David Cassidy, Eleanor Boyle, Pierre Côté, Yaohua He, Sheilah Hogg‐Johnson, Frank L. Silver, Susan J. Bondy	10
14	Risk of Vertebrobasilar Stroke and Chiropractic Care 2008 ·Spine ·J. David Cassidy, Eleanor Boyle, Pierre Côté, Yaohua He, Sheilah Hogg‐Johnson, Frank L. Silver, Susan J. Bondy	177
15	Nonparametric statistical inference method for partial areas under receiver operating characteristic curves, with application to genomic studies 2008 ·Statistics in Medicine ·Yaohua He, Michael Escobar	22
16	Effectiveness and Safety of Drug-Eluting Stents in Ontario 2007 ·New England Journal of Medicine ·Jack V. Tu, James M. Bowen, Maria Chiu, Dennis T. Ko, Peter C. Austin, Yaohua He, Robert Hopkins, Jean‐Éric Tarride, Gord Blackhouse, Charles Lazzam, Eric A. Cohen, Ron Goeree	268
17	Reliability analysis for continuous measurements: Equivalence test for agreement 2007 ·Statistics in Medicine ·Qilong Yi, Peter Wang, Yaohua He	30
18	A New Treatment Strategy for Severe Arthrofibrosis of the Knee 2006 ·Journal of Bone and Joint Surgery ·Jianhua Wang, Jinzhong Zhao, Yaohua He	27
19	Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000. 2003 ·PubMed Central ·Jo Anne Chiavetta, Michael Escobar, Alice Newman, Yaohua He, Pete Driezen, Shelley L. Deeks, (unknown), Sheila F. O’Brien, Graham D. Sher	102
20	[Arthroscopic treatment of tibial eminence fracture with figure-of-eight suture fixation technique]. 2003 ·PubMed ·Jinzhong Zhao, Yao Jiang, Hao Shen, Junjie Shao, Yaohua He	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact